Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Revenue (2016 - 2025)

Phibro Animal Health has reported Revenue over the past 14 years, most recently at $373.9 million for Q4 2025.

  • Quarterly results put Revenue at $373.9 million for Q4 2025, up 20.9% from a year ago — trailing twelve months through Dec 2025 was $1.5 billion (up 32.39% YoY), and the annual figure for FY2025 was $1.3 billion, up 27.37%.
  • Revenue for Q4 2025 was $373.9 million at Phibro Animal Health, up from $363.9 million in the prior quarter.
  • Over the last five years, Revenue for PAHC hit a ceiling of $378.7 million in Q2 2025 and a floor of $211.7 million in Q1 2021.
  • Median Revenue over the past 5 years was $252.5 million (2023), compared with a mean of $270.2 million.
  • Biggest five-year swings in Revenue: dropped 0.5% in 2023 and later skyrocketed 39.73% in 2025.
  • Phibro Animal Health's Revenue stood at $232.7 million in 2021, then increased by 5.13% to $244.6 million in 2022, then grew by 2.17% to $249.9 million in 2023, then rose by 23.73% to $309.3 million in 2024, then rose by 20.9% to $373.9 million in 2025.
  • The last three reported values for Revenue were $373.9 million (Q4 2025), $363.9 million (Q3 2025), and $378.7 million (Q2 2025) per Business Quant data.